Home NDC 61919-331 ACYCLOVIR
Product NDC 61919-331
11-digit product format 619190331
Labeler code 61919
Product ID 61919-331_8e6e3ffb-a885-ec6b-e053-2a95a90a6dda
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ACYCLOVIR
Dosage form CAPSULE
Route ORAL
Labeler Direct_Rx
Application ANDA075677
Marketing category ANDA
Marketing start 2019-07-24
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 200 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61919-331-30 ACYCLOVIR 30 in 1 BOTTLE CAPSULE 30 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61919-331 ACYCLOVIR CAPSULE [DIRECT_RX] 1 Legacy NDC, 1 package rows 20190724_8e6e3ffb-a884-ec6b-e053-2a95a90a6dda.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 61919-331-30 61919033130 30 CAPSULE in 1 BOTTLE (61919-331-30) 30 capsule 2019-07-24 0000-00-00 No No Current